Advertisement
Hormonal status seems to interact with genetic variants to influence cardiovascular phenotypes

Hormonal Status Impacts Genetic Variation, CIMT Link

0
SNPs within the innate immunity pathway altered the treatment effect on four-year change in CIMT
Under 17 percent of adults said they smoked in 2014

CDC: Adult Smoking Rate Falls to New Low in the United States

0
As of 2014, rate is 16.8 percent but big socioeconomic disparities remain
For patients with acute coronary syndrome managed with invasive procedures

Radial Artery Access Reduces Mortality, Major Bleeds in ACS

0
Fewer bleeding events, lower mortality rates when compared to femoral artery access
Exercise stress electrocardiography can yield substantial data from risk stratification in suspected or known coronary artery disease

Exercise Stress ECG Underutilized As Initial Test for Suspected CAD

0
Optimal test selection for symptomatic patients requires patient-centered approach

American Heart Association, Nov. 7-11

0
The American Heart Association's 2015 Scientific Sessions The annual meeting of the American Heart Association was held from Nov. 7 to 11 in...
About 47 percent of individuals with hypertension do not have the condition under control

CDC: Half of Americans With HTN Don’t Have BP Under Control

0
Improvement since 1999, but still short of Healthy People 2020 goal
Although obesity rates continued to climb among U.S. adults over the past decade

CDC: Adult Obesity Still Rising in U.S., Youth Rates Hold Steady

0
Per analysis of weight trends since 1999
Patients with stable ischemic heart disease who undergo percutaneous coronary intervention fare no better than those treated with medication and lifestyle changes alone

PCI May Not Improve Survival for Some Heart Disease Patients

0
Findings in patients with stable ischemic heart disease
Andexanet alfa can reverse the anticoagulant effects of factor Xa inhibitors

AHA: Andexanet Alfa Can Reverse Effect of Factor Xa Inhibitors

0
Reversal of anticoagulant activity of apixaban and rivaroxaban seen in older healthy participants
Patients with heart failure initiating mineralocorticoid receptor antagonists are rarely monitored in accordance with guidelines. The findings were published in the Nov. 10 issue of the Journal of the American Medical Association

AHA: Infrequent Monitoring for Heart Failure Patients on MRAs

0
Low monitoring rates in clinical practice in patients initiating mineralocorticoid receptor antagonists